Recurrent Meningioma: [177Lu]Lu-DOTATATE Treatment Study

We are investigating whether [177Lu]Lu-DOTATATE can effectively treat recurrent meningioma compared to standard care. The study will also look at safety and quality of life for participants.

>2 years 11-15 visits Efficacy phase (II)No Placebo Standard Medicines Oral InjectionNeurologyOncology

What diseases are being studied?

Health conditions and diseases that the clinical trial is designed to study and treat.

Who can participate in the clinical trial?

These questions help us understand your situation so we can let the trial team know whether you might be a potential match. This is not a medical evaluation and is not part of the official screening, the study doctor will make the final decision..

What medicines are being studied?

Medicines that are officially approved for use in the European Union and considered safe by EMA. These medicines are already on the market and may be tested for new conditions or populations.

Lutathera

Lutathera is a targeted radiation medicine used to treat certain neuroendocrine tumors that start in the digestive system or pancreas.

Octreotide

Octreotide is a medicine that reduces excess hormone effects, used for conditions like acromegaly and certain hormone-secreting tumors.

Sunitinib

Sunitinib is a cancer medicine used to treat certain kidney cancers and tumors of the digestive tract and pancreas.

What active substances are being studied?

Active substances that are officially approved for use in the European Union and considered safe by EMA. These substances are already on the market and may be tested for new conditions or populations.

Bevacizumab

Bevacizumab is a substance that blocks formation of new blood vessels to treat certain cancers and eye conditions caused by abnormal vessel growth.

Everolimus

Everolimus is a substance that suppresses the immune system to prevent organ rejection and helps slow growth of certain cancers.

Hydroxycarbamide

Hydroxycarbamide is a substance used to treat certain blood cancers and reduce painful crises in sickle cell disease.

What similar medicines might you know?

Don't worry if you don't know the medicines tested in the trial. There is a chance you have heard about the similar medicines. Check the list below to see if you are familiar with any of them.

Egotux

Klertis

Lusmose

Where is the clinical trial being conducted?

Locations and medical facilities where this clinical trial is currently recruiting or conducting research. Select the locations where you would like to participate.

Loading map...

Medizinische Universitaet Innsbruck

Universitätsklinik für Neurochirurgie

Innsbruck, Austria

Medical University Of Vienna

Department of Medicine I, Division of Oncology

Vienna, Austria

Hospices Civils De Lyon

Neuro-oncology

Bron, France

Sponsor: Europese Organisatie Voor Onderzoek En Behandeling Van Kanker Organisation Europeenne Pour La Recherche Et Le Traitement Du Cancer European Organi

Last updated: Nov 27, 2025

Disclaimer: Parts of this content have been automatically extracted from the EU Clinical Trials registry. While we strive for accuracy, please always contact the trial site or sponsor directly for correct and official information before making any decisions about participation. View on EU Clinical Trials.